ViroBlock, a Hebrew University Startup, Announces Preliminary Success of its Anti-Viral Drug Platform in New Study

 Targeting the Most Common Viruses: A Novel Platform Technology Yields a New Drug that Could Treat Current and Future COVID-19 Variants Similar Efforts Show Promise against Influenza, Zika, West Nile, Hepatitis and Future Threats JERUSALEM, June 27, 2022 – ViroBlock, a startup company founded by...

Related Keywords

New York ,United States ,Boston ,Massachusetts ,Jerusalem ,Israel General ,Israel ,Nile ,Hebrew University ,Yerushalayim ,American ,Instagram Youtube ,Boston Scientific ,American Friends Of The Hebrew University ,Novartis ,Hebrew University Of Jerusalem ,Alexander Silberman Institute Of Life Sciences ,A Novel Platform Technology ,Hebrew University Of Jerusalem Is Israel ,Johnson ,Intel ,Most Common Viruses ,Novel Platform Technology Yields ,New Drug ,Could Treat Current ,Efforts Show Promise ,West Nile ,Founder Isaiah ,Alexander Silberman Institute ,Nobel Prizes ,Fields Medal ,American Friends ,